Page last updated: 2024-10-20

phosphorylethanolamine and Alveolar Bone Atrophy

phosphorylethanolamine has been researched along with Alveolar Bone Atrophy in 2 studies

phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, YH1
Jiang, J1
Zhu, Q1
AlAnezi, AZ1
Clark, RB1
Jiang, X1
Rowe, DW1
Nichols, FC1
Watanabe, H1
Hashimoto-Uoshima, M1
Goseki-Sone, M1
Orimo, H1
Ishikawa, I1

Other Studies

2 other studies available for phosphorylethanolamine and Alveolar Bone Atrophy

ArticleYear
Porphyromonas gingivalis lipids inhibit osteoblastic differentiation and function.
    Infection and immunity, 2010, Volume: 78, Issue:9

    Topics: Alveolar Bone Loss; Animals; Apoptosis; Cell Differentiation; Cell Proliferation; Cells, Cultured; C

2010
A novel point mutation (C571T) in the tissue-non-specific alkaline phosphatase gene in a case of adult-type hypophosphatasia.
    Oral diseases, 2001, Volume: 7, Issue:6

    Topics: Alanine; Alkaline Phosphatase; Alleles; Alveolar Bone Loss; Chromosomes, Human, Pair 1; Cytosine; Et

2001